JCO Precision Oncology Conversations

JCO Precision Oncology Conversations

Por: American Society of Clinical Oncology (ASCO)
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.
62 episodios disponibles

Latest episodes of the podcast JCO Precision Oncology Conversations

Palbociclib in Tumors with CDKN2A Loss or Mutation 07/01/2026
FGFR3 Alteration Status and Immunotherapy in Urothelial Cancer 17/12/2025
JCO PO Article Insights: Genomic Risk Classifiers in Localized Prostate Cancer 26/11/2025
DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas 19/11/2025
Somatic Mutations of Colorectal Cancer by Birth Cohort 29/10/2025
Areas of Uncertainty in Pancreatic Cancer Surveillance 11/10/2025
Lynch Syndrome Mortality in the Immunotherapy Era 11/10/2025
JCO PO Article Insights: A Retrospective Analysis to Identify ICI-Sensitive Populations 30/09/2025
Genomic Profile of Small Cell Bladder, Lung and Urothelial Cancer 24/09/2025
JCO PO Article Insights: MUC16 Directed BiTE Therapy in Epithelioid Sarcoma 27/08/2025
BRCA-Altered Uterine Sarcoma Treated with PARP Inhibitors 20/08/2025
JCO PO Article Insights: Prognostic Gene Expression Signature and MYC Expression in Osteosarcoma 30/07/2025
JCO PO Article Insights: Prognostic Gene Expression Signature and MYC Expression in Osteosarcoma 30/07/2025
JCO PO Article Insights: Real-Time Monitoring in RCC with ctDNA 25/06/2025
A Position Paper on ctDNA Testing in Clinical Trials 18/06/2025
JCO PO Article Insights: TMB and Real-World ICI Outcomes in Melanoma 28/05/2025
Effectiveness and Cost-Effectiveness of Gene Panels in Melanoma 21/05/2025
JCO PO Article Insights: Exceptional Responders with Abexinostat and Pazopanib 30/04/2025
Prognostic Artificial Intelligence Scores and Outcomes in Nonmetastatic Prostate Cancer 16/04/2025
JCO PO Article Insights: Prognostic Artificial Intelligence Nonmetastatic Prostate Cancer 26/03/2025
1 2 3 4 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA